1. Home
  2. TRDA vs RC Comparison

TRDA vs RC Comparison

Compare TRDA & RC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

N/A

Current Price

$5.11

Market Cap

275.3M

Sector

Health Care

ML Signal

N/A

Logo Ready Capital Corproation

RC

Ready Capital Corproation

N/A

Current Price

$0.82

Market Cap

272.6M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
TRDA
RC
Founded
2016
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
275.3M
272.6M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
TRDA
RC
Price
$5.11
$0.82
Analyst Decision
Strong Buy
Hold
Analyst Count
7
7
Target Price
★ $18.75
$1.12
AVG Volume (30 Days)
460.4K
★ 2.5M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
★ 4.39%
EPS Growth
N/A
★ 45.25
EPS
N/A
★ N/A
Revenue
★ $25,421,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$709.43
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.11
$0.83
52 Week High
$16.45
$2.80

Technical Indicators

Market Signals
Indicator
TRDA
RC
Relative Strength Index (RSI) 49.88 34.28
Support Level $4.18 N/A
Resistance Level $5.13 $1.22
Average True Range (ATR) 0.49 0.12
MACD 0.12 -0.01
Stochastic Oscillator 68.02 1.76

Price Performance

Historical Comparison
TRDA
RC

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About RC Ready Capital Corproation

Ready Capital Corp is a real estate finance company that originates, acquires, finances, and services LMM loans, SBA loans, construction loans, USDA loans and, to a lesser extent, MBS collateralized mainly by LMM loans or other real estate-related investments. Its loans are used by businesses to purchase real estate used in their operations or by investors seeking to acquire multi-family, office, retail, mixed use or warehouse properties. It operates through two segments: LMM Commercial Real Estate, which originates LMM loans across the life-cycle of an LMM property including construction, bridge, stabilized and agency loan channels, and Small Business Lending, which acquires, originates and services owner-occupied loans guaranteed by the SBA and also originates and services USDA loans.

Share on Social Networks: